A rise in various complex diseases and medical conditions has led the healthcare sector to push research and development boundaries which have resulted in a new age of disease treatment and one such technology is Implantable Pulse Generator (IPG). It is a micro-electronic medical device which is battery-powered that is inserted in the body where the nervous system is delivered with an electric stimulation which helps in stimulation or blocking of different nerve impulses in the body. It is a promising technology which has been adapted from cardiac rhythm management technology which has helped in curing various medical conditions like hypertension treatment, back pain, obesity and diabetes without a daily dosage of insulin. It is also used in situations where medicines are partially ineffective or have started to show some side effects. On the other hand, it can also be combined with medicine to control the progression of the disease. For instance, implantable pulse generator is primarily used for treating Parkinson's disease, dystonia and tremor using Deep Brain Stimulation (DBS). The global implantable pulse generator market is expected to witness a growth during the forecast period of 2019-2026 due to rising prevalence of cardiovascular and neurological disorders. Other factors like easy implantation along with enhanced clinical performance, greater awareness in patients and strong reimbursements have led to an increase in market penetration across the world.